We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+39.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$370M
Cap. Flow
-$141M
Cap. Flow %
-1.39%
Top 10 Hldgs %
14%
Holding
622
New
136
Increased
89
Reduced
249
Closed
24

Top Buys

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$92.7M
2
FRC
First Republic Bank
FRC
+$73.7M
3
BP icon
BP
BP
+$67.2M
4
KHC icon
Kraft Heinz
KHC
+$62.4M
5
HUM icon
Humana
HUM
+$56.3M

Sector Composition

Rank Sector Weight
1 Financials 16.41%
2 Industrials 15.8%
3 Healthcare 10.6%
4 Technology 10.4%
5 Energy 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
351
Madrigal Pharmaceuticals
MDGL
$12.3B
$402K ﹤0.01%
+4,382
New +$250K
CMD
352
DELISTED
Cantel Medical Corporation
CMD
$400K ﹤0.01%
3,886
-329
-8% -$32.8K
ESPR
353
DELISTED
Esperion Therapeutics
ESPR
$399K ﹤0.01%
+6,057
New +$326K
MYOK
354
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$398K ﹤0.01%
+9,447
New +$364K
PAYC icon
355
Paycom
PAYC
$9.87B
$396K ﹤0.01%
4,925
-418
-8% -$33.4K
COHR
356
DELISTED
Coherent Inc
COHR
$395K ﹤0.01%
1,400
-118
-8% -$32.9K
RETA
357
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$394K ﹤0.01%
+13,917
New +$388K
ARNA
358
DELISTED
Arena Pharmaceuticals Inc
ARNA
$393K ﹤0.01%
+11,580
New +$330K
FOLD
359
DELISTED
Amicus Therapeutics
FOLD
$392K ﹤0.01%
+27,241
New +$374K
KURA icon
360
Kura Oncology
KURA
$1.03B
$392K ﹤0.01%
+25,648
New +$378K
VYGR icon
361
Voyager Therapeutics
VYGR
$197M
$392K ﹤0.01%
+23,586
New +$404K
CBAY
362
DELISTED
Cymabay Therapeutics
CBAY
$391K ﹤0.01%
+42,485
New +$363K
AIMT
363
DELISTED
Aimmune Therapeutics
AIMT
$391K ﹤0.01%
+10,336
New +$334K
VSM
364
DELISTED
Versum Materials, Inc.
VSM
$391K ﹤0.01%
10,320
-875
-8% -$34.1K
CHE icon
365
Chemed
CHE
$6.72B
$390K ﹤0.01%
1,605
-136
-8% -$30.9K
HEFA icon
366
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.44B
$389K ﹤0.01%
12,961
QURE icon
367
uniQure
QURE
$3.09B
$389K ﹤0.01%
+19,842
New +$302K
ANAB icon
368
AnaptysBio
ANAB
$1.6B
$387K ﹤0.01%
+3,844
New +$283K
ARDX icon
369
Ardelyx
ARDX
$924M
$386K ﹤0.01%
+58,441
New +$346K
RIGL icon
370
Rigel Pharmaceuticals
RIGL
$882M
$383K ﹤0.01%
+9,873
New +$376K
ACGN
371
DELISTED
Aceragen Inc
ACGN
$381K ﹤0.01%
+166
New +$379K
FPRX
372
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$381K ﹤0.01%
+17,371
New +$559K
KWR icon
373
Quaker Houghton
KWR
$2.69B
$380K ﹤0.01%
2,518
-213
-8% -$32.9K
AGIO icon
374
Agios Pharmaceuticals
AGIO
$2.01B
$379K ﹤0.01%
+6,624
New +$417K
ILG
375
DELISTED
ILG, Inc Common Stock
ILG
$379K ﹤0.01%
13,320
-1,131
-8% -$32.6K

Similar funds

Virtus Fund Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Virtus Fund Advisers held 622 positions worth $10.2B, up 3.8% from $9.81B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Virtus Fund Advisers's Q4 2017 filing shows 136 new, 89 increased, 249 reduced and 24 closed positions. Its largest new stake was BP: 1,855,977 shares worth $71.4M. The largest sale was Edison International, an estimated $74.9M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

  • Virtus Fund Advisers's largest Q4 2017 buy was BP: 1,855,977 shares worth $71.4M.
  • Virtus Fund Advisers added most to Republic Services in Q4 2017, an estimated $92.7M increase.
  • Virtus Fund Advisers's biggest Q4 2017 reduction was Public Storage, cutting an estimated $53.8M.
  • Virtus Fund Advisers fully exited Edison International in Q4 2017, selling an estimated $74.9M.
  • Virtus Fund Advisers's ten largest holdings make up 14% of its $10.2B portfolio in Q4 2017.
  • Virtus Fund Advisers opened 136 new positions and closed 24 in Q4 2017.
  • Virtus Fund Advisers's portfolio value rose 3.8% quarter-over-quarter to $10.2B.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.